Literature DB >> 6995329

In vitro phagocytosis of Candida albicans by peritoneal mouse macrophages.

R Evron.   

Abstract

The ability of sensitized mouse peritoneal macrophages to phagocytose and inhibit Candida albicans was studied in an in vitro system. Mice were sensitized to C. albicans by intraperitoneal infection with viable organisms or by intracutaneous injection of heat-inactivated cells in Freund complete adjuvant. Development of delayed hypersensitivity to C. albicans was evaluated by footpad tests with cytoplasmic and cell wall antigens as well as by macrophage migration inhibition by these antigens and by whole heat-inactivated cells. Inhibition of macrophage migration by heat-inactivated cells was significantly greater when the mice were sensitized by viable organisms. The macrophages from these mice were also larger and showed a greaer ability to inhibit germ tube production by phagocytosed yeasts. This suggests that macrophages may play a protective role in infection by C. albicans.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6995329      PMCID: PMC551045          DOI: 10.1128/iai.28.3.963-971.1980

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  41 in total

1.  The role of macrophages in Candida albicans infection in vitro.

Authors:  K Ozato; I Uesaka
Journal:  Jpn J Microbiol       Date:  1974-01

Review 2.  The relationship of delayed hypersensitivity to acquired cellular resistance.

Authors:  G B Mackaness
Journal:  Br Med Bull       Date:  1967-01       Impact factor: 4.291

3.  Antifungal effects of peroxidase systems.

Authors:  R I Lehrer
Journal:  J Bacteriol       Date:  1969-08       Impact factor: 3.490

4.  The fungicidal mechanisms of human monocytes. I. Evidence for myeloperoxidase-linked and myeloperoxidase-independent candidacidal mechanisms.

Authors:  R I Lehrer
Journal:  J Clin Invest       Date:  1975-02       Impact factor: 14.808

5.  Cellular immunity in vitro: migration inhibition and phagocytosis.

Authors:  R Neta; S B Salvin
Journal:  Infect Immun       Date:  1971-12       Impact factor: 3.441

6.  In vitro bactericidal capacity of human polymorphonuclear leukocytes: diminished activity in chronic granulomatous disease of childhood.

Authors:  P G Quie; J G White; B Holmes; R A Good
Journal:  J Clin Invest       Date:  1967-04       Impact factor: 14.808

7.  Functional aspects of a second mechanism of candidacidal activity by human neutrophils.

Authors:  R I Lehrer
Journal:  J Clin Invest       Date:  1972-10       Impact factor: 14.808

8.  Leukocyte myeloperoxidase deficiency and disseminated candidiasis: the role of myeloperoxidase in resistance to Candida infection.

Authors:  R I Lehrer; M J Cline
Journal:  J Clin Invest       Date:  1969-08       Impact factor: 14.808

9.  The influence of immunologically committed lymphoid cells on macrophage activity in vivo.

Authors:  G B Mackaness
Journal:  J Exp Med       Date:  1969-05-01       Impact factor: 14.307

10.  THE IMMUNOLOGICAL BASIS OF ACQUIRED CELLULAR RESISTANCE.

Authors:  G B MACKANESS
Journal:  J Exp Med       Date:  1964-07-01       Impact factor: 14.307

View more
  15 in total

1.  Augmentation of GG2EE macrophage cell line-mediated anti-Candida activity by gamma interferon, tumor necrosis factor, and interleukin-1.

Authors:  E Blasi; S Farinelli; L Varesio; F Bistoni
Journal:  Infect Immun       Date:  1990-04       Impact factor: 3.441

Review 2.  Macrophages in resistance to candidiasis.

Authors:  A Vázquez-Torres; E Balish
Journal:  Microbiol Mol Biol Rev       Date:  1997-06       Impact factor: 11.056

3.  Isolation and characterization of cell wall and cytoplasmic antigens and peripheral blood leukocyte responses in rabbits immunized with Candida albicans.

Authors:  Y E Shi
Journal:  Acta Acad Med Wuhan       Date:  1985

4.  In vitro phagocytosis of several Candida berkhout species by murine leukocytes.

Authors:  S E Fontenla de Petrino; M E Bibas Bonet de Jorrat; A Sirena
Journal:  Mycopathologia       Date:  1985-03       Impact factor: 2.574

5.  In vitro determination of phagocytic indices of Candida berkhout species by rat peritoneal macrophages.

Authors:  R Salim; A van Gelderen de Komaid
Journal:  Mycopathologia       Date:  1985-01       Impact factor: 2.574

Review 6.  An overview of macrophage-fungal interactions.

Authors:  R A Fromtling; H J Shadomy
Journal:  Mycopathologia       Date:  1986-02       Impact factor: 2.574

7.  In vitro modification of Candida albicans invasiveness.

Authors:  S E Fontenla de Petrino; M E de Jorrat; A Sirena; J C Valdez; O Mesón
Journal:  Mycopathologia       Date:  1986-05       Impact factor: 2.574

8.  Preincubation of Candida albicans strains with amphotericin B reduces tumor necrosis factor alpha and interleukin-6 release by human monocytes.

Authors:  G Raponi; M C Ghezzi; C Mancini; F Filadoro
Journal:  Antimicrob Agents Chemother       Date:  1993-09       Impact factor: 5.191

9.  Role of antibodies and effect of BCG vaccination in experimental candidiasis in mice.

Authors:  P K Maiti; A Kumar; R Kumar; L N Mohapatra
Journal:  Mycopathologia       Date:  1985-08       Impact factor: 2.574

10.  Effects of amphotericin B and fluconazole on the extracellular and intracellular growth of Candida albicans.

Authors:  E W van Etten; N E van de Rhee; K M van Kampen; I A Bakker-Woudenberg
Journal:  Antimicrob Agents Chemother       Date:  1991-11       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.